Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension

American Heart Journal

Volumn 145, Issue 2, 2003, Pages 310-316

  Gavazzi, Antonello ^a   Ghio, Stefano ^a   Scelsi, Laura ^a   Campana, Carlo ^a   Klersy, Catherine ^a   Serio, Alessandra ^a   Raineri, Claudia ^a   Tavazzi, Luigi ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFECT; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL; THERMODILUTION; VASODILATATION;

EID: 0037323595     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.146     Document Type: Article

References (20)

1. Drazner MH, Hamilton MA, Fonarow G, et al. Relationship between right- and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant 1999;18:1126-32.
2. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000;102:1718-23.
3. Abramson SV, Burke JF, Kelly JJ Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992;116:888-95.
4. Hunt SA. Pulmonary hypertension in severe congestive heart failure: how important is it? J Heart Lung Transplant 1997;16:S13-5.
5. Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-6
6. Kawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplant recipient with preoperative pulmonary hypertension: evolution of pulmonary hemodynamics and surgical options. Circulation 1989;80(3 Suppl):90-6.
7. Costard-Jackle A, Hill I, Schroeder JS, et al. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991;84(3 Suppl):329-37.
8. Murali S, Kormos RL, Uretski BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126:896-904.
9. Mudge GH, Goldstein S, Addonizio LJ, et al. Twenty-fourth Bethesda Conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization. J Am Coll Cardiol 1993;22:21-31.
10. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992;19:48-54.
11. Di Salvo TG, Mathier M, Semigran MJ, et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995;25:1143-53.
12. Gavazzi A, Berzuini C, Campana C, et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant 1997;16:774-85.
13. Juillière Y, Barbier G, Feldmann L, et al. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997;18:276-80.
14. De Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998;32:948-54.
15. Ghio S, Recusani F, Klersy C, et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 2000;85:837-42.
16. Gorcsan J III, Murali S, Counihan PJ, et al. Right ventricular performance and contractile reserve in patients with severe heart failure: assessment by pressure-area relation and association with outcome. Circulation 1996;94:3190-7.
17. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular function and pulmonory artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37:183-8.
18. Murali S, Uretsky BF, Armitage JM, et al. Utility of prostaglandin E in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 1992;11:716-23.
19. Adatia I, Perry S, Landzberg M, et al. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25:1656-64.
20. Givertz MM, Hare JM, Loh E, et al. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 1996;28:1775-80.